Nav: Home

The Lancet Infectious Diseases: Experts warn of a surge in vector-borne diseases as humanitarian crisis in Venezuela worsens

February 21, 2019

  • Worsening epidemics could spread beyond Venezuelan borders, potentially causing a public health emergency of 'hemispheric concern'.
  • Many solutions are possible, even with scarce resources, and national, regional, and global health authorities must act.
The ongoing humanitarian crisis in Venezuela is accelerating the re-emergence of vector-borne diseases such as malaria, Chagas disease, dengue, and Zika virus, and threatens to jeopardise public health gains in the country over the past two decades, warn leading public health experts. The conclusion comes from a Review paper that provides the most comprehensive assessment of the impact of the crisis in Venezuela, published in The Lancet Infectious Diseases journal.

With the collapse of the health care system and the dramatic decline in public health programmes and disease surveillance, vector-borne diseases (which are transmitted by insects such as mosquitoes and ticks) are on the rise and have spread into new territories across Venezuela--once a regional leader in public health and vector control, and the first WHO-certified country to eradicate malaria in 1961.

This is the first time so much information has been brought together to assess the impact of Venezuela's health crisis on vector-borne diseases. However, the authors caution that given the lack of disease surveillance and public health infrastructure available for diagnosis, the true burden of disease remains unknown.

Worryingly, the authors say that this might be just the tip of the iceberg. "As well as the return of measles and other vaccine-preventable infectious diseases, the continued upsurge in malaria could soon become uncontrollable. The stark reality is that in the absence of surveillance, diagnostic, and preventive measures, these figures most likely represent an underestimate of the true situation", says Dr Martin Llewellyn from the University of Glasgow, UK, who led the research with Venezuelan, Colombian, Brazilian, and Ecuadorian colleagues. [1]

Analysis of published and unpublished data (see panel) indicate that between 2010 (29,736 cases) and 2015 (136,402 cases), Venezuela experienced an estimated 359% increase in malaria cases, followed by a 71% increase between 2016 (240,613 cases) and 2017 (411,586 cases) because of a decline in mosquito-control activities and shortages in medication. This is potentially the largest malaria increase reported worldwide. Worse still, say the authors, endemic malaria transmission is beginning to spread across the whole country (figure 1).

Findings from the review suggest that the ongoing crisis has also had dramatic effects on other vector-borne diseases. For example, Chagas disease, one of the leading causes of heart failure in Latin America, may be resurging, with active Chagas disease transmission the highest seen in 20 years. Based on samples collected between 2008 and 2018 seroprevalence among children younger than 10 years was estimated at 12.5% in some communities, compared to an all-time low of 0.5% in 1998 (figure 3).

The incidence of dengue has risen more than five-fold, with an average incidence of 211 cases per 100,000 people between 2010 and 2016, and six increasingly large epidemics recorded nationally between 2007 and 2016, compared with four in the previous 16 years (figure 5).

Similarly, the frequency of chikungunya and Zika outbreaks with epidemic potential appear to be increasing, with an estimated 2 million suspected chikungunya cases in 2014 (incidence 6,975 per 100,000)--more than 12 times higher than official national estimates.

The findings also sit in the context of mass emigration. With an average of 5,500 people leaving the country every day in 2018 [2], neighbouring countries are also facing major challenges. For instance, regions of Brazil neighbouring Venezuela have reported an escalating trend in malaria cases (eg. Roraima saw the number of imported cases of malaria rise from 1,538 cases in 2014 to 3,129 in 2017 (figure 2)), but rates in other neighbouring countries remain unclear. The authors highlight that many solutions are possible, even with limited resources. For example, in recent years, malaria has been successfully controlled on the Ecuador-Peru border through bi-national collaboration that involved strengthening surveillance and treatment strategies, and sharing of resources (eg, information, personnel, medication, and insecticides) [3].

Reaching and testing those at risk of infection across Venezuela is a major challenge, say the authors, so it is especially important that communities most at-risk from disease are made aware of the growing threat. Additionally, more needs to be done to improve surveillance and data sharing. The authors point out that surveillance is crucial and must be used to raise awareness among Venezuelan and regional authorities, and encourage them to recognise the growing crisis, cooperate, and accept international medical interventions. Relevant international health authorities must also take action to maintain accurate disease surveillance and response systems in the region.

Successful control of the emerging health crisis will require regional coordination and powerful national and international political commitment, and the authors urge regional health-care authorities to recognise and act on a public health emergency of hemispheric concern.

"We call on the members of the Organization of American States and other international political bodies to apply more pressure to the Venezuelan government to accept the humanitarian assistance offered by the international community in order to strengthen the buckling health system. Without such efforts, the public health gains achieved over the past 18 years could soon be reversed", warns Llewellyn. [1]
Peer-reviewed / Review / People


This study was conducted by researchers from Universidad Central de Venezuela, Caracas, Venezuela; University of Glasgow, Glasgow, Scotland, UK; Instituto de Investigaciones Biomédicas IDB, Clinica IDB Cabudare, Lara State, Venezuela; Instituto de Estudios Avanzados, Caracas, Venezuela; University of Groningen, Groningen, Netherlands; Universidad Centrooccidental Lisandro Alvarado, Barquisimeto, Lara State, Venezuela; Universidad Nacional Experimental Francisco de Miranda, Punto Fijo, Falcón State, Venezuela; University of Florida, Gainesville, FL, USA; Universidad Católica del Ecuador, Quito, Ecuador; Ohio University, Athens, OH, USA; London School of Hygiene and Tropical Medicine, London, UK; Liverpool School of Tropical Medicine, Liverpool, UK; Venezuelan National Academy of Medicine, Caracas, Venezuela; New York State Department of Health, Albany, NY, USA; University at Albany, NY, USA; Instituto Venezolano de los Seguros Sociales, Caracas, Venezuela; Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina; Baylor College of Medicine, Houston, TX, USA; Jichi Medical University, Tochigi, Japan; Universidad de Valencia, Valencia, Spain; Universidad Internacional SEK, Quito, Ecuador; Instituto de Estudios Avanzados, Caracas, Venezuela; Venezuelan Institute for Scientific Research, Miranda State, Venezuela; Asociación Civil Impacto Social, Tumeremo, Bolívar State, Venezuela; Instituto Leônidas e Maria Deane ILMD/FIOCRUZ, Laboratório de Ecologia de Doenças Transmissíveis na Amazônia, Manaus, Amazonas, Brazil; Centro de Investigaciones de Campo "Dr Francesco Vitanza", Servicio Autónomo Instituto de Altos Estudios "Dr Arnoldo Gabaldon", MPPS, Tumeremo, Bolívar, Venezuela; and Grupo de Investigaciones Microbiológicas - UR, Programa de Biología, Universidad del Rosario, Bogotá, Colombia.

[1] Quotes direct from authors and cannot be found in the text of the Article.



The labels have been added to this press release as part of a project run by the Academy of Medical Sciences seeking to improve the communication of evidence. For more information, please see: if you have any questions or feedback, please contact The Lancet press office

The Lancet

Related Malaria Articles:

Could there be a 'social vaccine' for malaria?
Malaria is a global killer and a world health concern.
Transgenic plants against malaria
Scientists have discovered a gene that allows to double the production of artemisinin in the Artemisia annua plant.
Fighting malaria through metabolism
EPFL scientists have fully modeled the metabolism of the deadliest malaria parasite.
Should we commit to eradicate malaria worldwide?
Should we commit to eradicate malaria worldwide, asks a debate article published by The BMJ today?
Investigational malaria vaccine shows considerable protection in adults in malaria season
An investigational malaria vaccine given intravenously was well-tolerated and protected a significant proportion of healthy adults against infection with Plasmodium falciparum malaria -- the deadliest form of the disease -- for the duration of the malaria season, according to new findings published in the Feb.
Why malaria mosquitoes like people with malaria
Malaria mosquitoes prefer to feed -- and feed more -- on blood from people infected with malaria.
Malaria superbugs threaten global malaria control
A lineage of multidrug resistant P. falciparum malaria superbugs has widely spread and is now established in parts of Thailand, Laos and Cambodia, causing high treatment failure rates for the main falciparum malaria medicines, artemisinin combination therapies (ACTs), according to a study published today in The Lancet Infectious Diseases.
Considering cattle could help eliminate malaria in India
The goal of eliminating malaria in countries like India could be more achievable if mosquito-control efforts take into account the relationship between mosquitoes and cattle, according to an international team of researchers.
Seasonal malaria chemoprevention in Senegalese children lowers overall malaria burden
Giving preventive antimalarial drugs to children up to age 10 during active malaria season reduced the cases of malaria in that age group and lowered the malaria incidence in adults, according to a randomized trial carried out in Senegal and published in PLOS Medicine by researchers from the Université Cheikh Anta Diop, Senegal, the London School of Hygiene & Tropical Medicine, UK, and other collaborators.
How malaria fools our immune system
OIST researchers reconstruct the 3-D structure of a malaria protein in combination with human antibodies.

Related Malaria Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Failure can feel lonely and final. But can we learn from failure, even reframe it, to feel more like a temporary setback? This hour, TED speakers on changing a crushing defeat into a stepping stone. Guests include entrepreneur Leticia Gasca, psychology professor Alison Ledgerwood, astronomer Phil Plait, former professional athlete Charly Haversat, and UPS training manager Jon Bowers.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".